
1. j ophthalmol. 1996 jul;122(1):121-3.

treatment clinically resistant cytomegalovirus retinitis combined
intravitreal injections ganciclovir foscarnet.

desatnik hr(1), foster re, lowder cy.

author information: 
(1)division ophthalmology, cleveland clinic foundation, oh 44195-5024, usa.
fosterr@cesmtp.ccf.org

purpose: determine efficacy combined ganciclovir foscarnet
intravitreal injections controlling clinically resistant cytomegalovirus
retinitis 37-year-old man acquired immunodeficiency syndrome who
refused systemic therapy.
methods: patient refused systemic therapy treated intravitreal
injections ganciclovir foscarnet, combined the
retinitis became resistant either drug alone.
results: retinitis initially controlled bilateral intravitreal
ganciclovir injections. reactivation retinitis left eye,
intravitreal foscarnet effective recurrent retinitis threatened the
center fovea. retinitis continued progress combined
intravitreal injections ganciclovir foscarnet administered.
conclusions: combined intravitreal injections ganciclovir foscarnet may be
effective treating cytomegalovirus retinitis infection clinically 
resistant either intravitreal drug alone. intravitreal injections be
effective controlling cytomegalovirus retinitis patients intolerant
of refuse systemic therapy.

doi: 10.1016/s0002-9394(14)71977-4 
pmid: 8659587  [indexed medline]

